Literature DB >> 2504666

Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gamma.

F Wagner1, N Fischer, C Lersch, R Hart, H Dancygier.   

Abstract

Interferon gamma (IFN gamma) inhibits many effects of interleukin (IL)-4. Its production largely parallels cell proliferation but is regulated independently. As IL-4 inhibits several IL-2-induced effects including proliferation of human peripheral blood mononuclear cells, we investigated its influence on the IL-2-induced IFN gamma production. We found that both absolute IFN gamma production and IFN gamma production per proliferation unit (1000 cpm) in response to IL-2 were inhibited by IL-4. IL-2-induced interferon production was inhibited by IL-4 in both sheep red blood cell rosetting and non-rosetting cells. In bidirectional mixed lymphocyte culture, IL-4 alone enhanced proliferation but suppressed IFN gamma production. As 48% of IFN gamma-producing cells are known to show T cell phenotype, the nearly total inhibition of IFN gamma production is evidence for suppression of T cell response to IL-2. Additionally, we found that the inhibition of IL-2-induced proliferation by IL-4 was significantly more pronounced at low cell densities. Basal proliferation was only inhibited in serum-containing media. These data stress the importance of other lymphokines or accessory cells in the regulation of early lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504666     DOI: 10.1016/0165-2478(89)90110-7

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  6 in total

Review 1.  The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Authors:  Jiemiao Hu; Jun Yan; Ganesh Rao; Khatri Latha; Willem W Overwijk; Amy B Heimberger; Shulin Li
Journal:  Int Rev Immunol       Date:  2014-09-26       Impact factor: 5.311

Review 2.  Targeting key proximal drivers of type 2 inflammation in disease.

Authors:  Namita A Gandhi; Brandy L Bennett; Neil M H Graham; Gianluca Pirozzi; Neil Stahl; George D Yancopoulos
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

3.  Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.

Authors:  B Brooks; K Chapman; J Lawry; A Meager; R C Rees
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

4.  Interleukin-4 enhances interferon-gamma synthesis but inhibits development of interferon-gamma-producing cells.

Authors:  A Noble; D M Kemeny
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

5.  In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation.

Authors:  R Appelberg; I M Orme; M I Pinto de Sousa; M T Silva
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

6.  Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice.

Authors:  F D Finkelman; A Svetic; I Gresser; C Snapper; J Holmes; P P Trotta; I M Katona; W C Gause
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.